TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Vicore Pharma AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
351
|
1,898
|
2,135 |
| Financial expenses |
1
|
3
|
315 |
| Earnings before taxes |
-189,306
|
-184,529
|
-212,223 |
| EBITDA |
-181,174
|
-184,635
|
-210,776 |
| Total assets |
76,808
|
81,792
|
135,964 |
| Current assets |
76,107
|
72,035
|
128,576 |
| Current liabilities |
46,877
|
32,848
|
66,445 |
| Equity capital |
29,387
|
48,287
|
69,341 |
| - share capital |
67
|
67
|
73 |
| Employees (average) |
19
|
16
|
12 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
38.3%
|
59.0%
|
51.0% |
| Turnover per employee |
18
|
119
|
178 |
| Profit as a percentage of turnover |
-53933.3%
|
-9722.3%
|
-9940.2% |
| Return on assets (ROA) |
-246.5%
|
-225.6%
|
-155.9% |
| Current ratio |
162.4%
|
219.3%
|
193.5% |
| Return on equity (ROE) |
-644.2%
|
-382.2%
|
-306.1% |
| Change turnover |
-1,557
|
-63
|
-27 |
| Change turnover % |
-82%
|
-3%
|
-1% |
| Chg. No. of employees |
3
|
4
|
3 |
| Chg. No. of employees % |
19%
|
33%
|
33% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.